News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,284 Results
Type
Article (31778)
Company Profile (58)
Press Release (362448)
Section
Business (112700)
Career Advice (1321)
Deals (24035)
Drug Delivery (92)
Drug Development (59642)
Employer Resources (102)
FDA (9912)
Job Trends (9071)
News (211312)
Policy (25478)
Tag
Academia (1830)
Alliances (42206)
Alzheimer's disease (1058)
Approvals (9900)
Artificial intelligence (129)
Bankruptcy (232)
Best Places to Work (7694)
Breast cancer (159)
Cancer (1276)
Cardiovascular disease (92)
Career advice (1109)
CAR-T (86)
Cell therapy (251)
Clinical research (47757)
Collaboration (557)
Compensation (304)
COVID-19 (2456)
Data (1178)
Diabetes (172)
Diagnostics (3518)
Drug pricing (91)
Earnings (39715)
Employer resources (94)
Events (45208)
Executive appointments (250)
FDA (10558)
Funding (386)
Gene therapy (190)
GLP-1 (636)
Government (4048)
Healthcare (11396)
Infectious disease (2565)
Interviews (229)
IPO (10416)
Job creations (1746)
Job search strategy (955)
Layoffs (263)
Legal (7034)
Lung cancer (188)
Lymphoma (86)
Manufacturing (179)
Medical device (5889)
Medtech (5890)
Mergers & acquisitions (13910)
Metabolic disorders (481)
Neuroscience (1371)
NextGen: Class of 2025 (3656)
Non-profit (2768)
Northern California (1308)
Obesity (283)
Opinion (184)
Parkinson's disease (93)
Patents (115)
People (24649)
Phase I (14433)
Phase II (20759)
Phase III (16803)
Pipeline (545)
Policy (89)
Postmarket research (1846)
Preclinical (5956)
Radiopharmaceuticals (200)
Rare diseases (230)
Real estate (2575)
Regulatory (15897)
Research institute (1589)
Resumes & cover letters (195)
Southern California (1071)
Startups (1881)
United States (10758)
Vaccines (643)
Weight loss (223)
Date
Today (51)
Last 7 days (371)
Last 30 days (1673)
Last 365 days (22019)
2025 (2813)
2024 (22352)
2023 (25258)
2022 (33380)
2021 (35888)
2020 (34072)
2019 (27908)
2018 (21234)
2017 (20187)
2016 (18693)
2015 (21494)
2014 (15949)
2013 (12876)
2012 (13623)
2011 (14401)
2010 (13078)
Location
Africa (567)
Asia (25724)
Australia (4639)
California (2851)
Canada (1044)
China (279)
Colorado (123)
Connecticut (131)
Europe (61643)
Florida (417)
Georgia (101)
Illinois (247)
Indiana (160)
Japan (93)
Maryland (552)
Massachusetts (2063)
Michigan (96)
Minnesota (114)
New Jersey (887)
New York (872)
North Carolina (428)
Northern California (1308)
Ohio (97)
Pennsylvania (634)
South America (794)
Southern California (1071)
Texas (359)
Washington State (261)
394,284 Results for "medigene ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medigene AG announces closing of its first SEPA tranche
February 4, 2025
·
2 min read
Press Releases
Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
February 19, 2025
·
2 min read
Press Releases
Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment
November 27, 2024
·
5 min read
Medigene AG reports Financial Results and Business Update for Q1 2024
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, reported financial results for the first quarter of 2024.
April 26, 2024
·
6 min read
Press Releases
Medigene AG Announces KRAS G12V as First Target for TCR-guided T Cell Engagers
December 9, 2024
·
6 min read
Medigene AG Secures European Patent for its iM-TCR Technology
Medigene AG announced that the Company has been issued a patent by the European Patent Office protecting its inducible Medigene T cell receptor technology, which contains a control mechanism to regulate efficacy and improve safety of its T cell receptor engineered T cell therapies.
April 4, 2024
·
4 min read
Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors
Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard) announces today that it has selected its lead candidate for MDG2021, a T cell receptor engineered T cell (TCR-T) therapy targeting Kirsten rat sarcoma viral oncogene homologue (KRAS) G12D with human leukocyte antigen (HLA)-A*11 being developed in combination with the Company’s PD1-41BB costimulatory switch protein (CSP) technology.
June 20, 2024
·
7 min read
Business
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
Medigene AG reported financial results for the fiscal year ended December 31, 2023, and provided a corporate update.
March 28, 2024
·
8 min read
Press Releases
Medigene AG reports Financial Results and Business Update for Q3 2024
October 24, 2024
·
6 min read
Policy
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announced the submission of three patents to the European Patent Office.
May 28, 2024
·
4 min read
1 of 39,429
Next
